Valuation: Enovis Corporation

Market Cap 1.48B 1.26B 1.18B 1.08B 2.04B 141B 2.06B 13.97B 5.44B 70.95B 5.54B 5.42B 235B P/E 2026 *
88.2x
P/E 2027 * 23.8x
Enterprise Value 2.69B 2.3B 2.16B 1.97B 3.72B 256B 3.76B 25.48B 9.92B 129B 10.1B 9.88B 428B EV / Sales 2026 *
1.15x
EV / Sales 2027 * 1.04x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day+1.47%
1 week-0.23%
Current month-12.25%
1 month-5.36%
3 months+5.75%
6 months+14.61%
Current year-3.98%
1 week 24.68
Extreme 24.68
26.93
1 month 23.62
Extreme 23.625
31.66
Current year 19.14
Extreme 19.14
31.66
1 year 19.14
Extreme 19.14
34.28
3 years 19.14
Extreme 19.14
65.03
5 years 19.14
Extreme 19.14
164.01
10 years 19.14
Extreme 19.14
164.01
Manager TitleAgeSince
Chief Executive Officer 61 11/05/2025
Director of Finance/CFO 47 31/12/2022
Chief Tech/Sci/R&D Officer - 31/12/2025
Director TitleAgeSince
Director/Board Member 55 12/05/2008
Director/Board Member 67 20/09/2010
Chairman 64 20/05/2025
Date Insider Type Main position Quantity % Market Cap.
30/06/26 Free

Director

846 0.0015%
31/03/26 Free

Director

770 0.0013%
07/03/26 Free

Chief Executive Officer

143,923 0.2518%
Change 5-day change 1-year change 3-year change Capi.($)
+1.47%-0.23%-17.46%-54.38% 1.48B
+0.85%-0.24%-15.42%+18.87% 127B
+0.49%+0.51%-22.17%+0.09% 12.25B
-2.29%-1.50%+98.13%+145.52% 10.69B
+2.13%-4.21%-51.63%-68.92% 4.19B
+0.57%+4.02%-22.01%+58.76% 2.78B
-0.65%+6.43%-34.28%-71.67% 1.77B
+1.12%-0.84%-23.32%-12.99% 1.64B
+0.47%-3.59%-36.96%-38.68% 1.57B
Average +0.46%+0.37%-13.90%-2.60% 18.13B
Weighted average by Cap. +0.63%-0.46%-10.04%+21.67%

Financials

2026 *2027 *
Net sales 2.34B 2B 1.88B 1.72B 3.24B 223B 3.27B 22.16B 8.63B 113B 8.78B 8.59B 373B 2.45B 2.1B 1.97B 1.8B 3.4B 234B 3.43B 23.24B 9.05B 118B 9.21B 9.01B 391B
Net income 11.5M 9.85M 9.23M 8.43M 15.92M 1.1B 16.07M 109M 42.4M 553M 43.18M 42.24M 1.83B 60.85M 52.14M 48.86M 44.63M 84.23M 5.8B 85.06M 576M 224M 2.93B 228M 224M 9.69B
Net Debt 1.21B 1.04B 975M 891M 1.68B 116B 1.7B 11.5B 4.48B 58.43B 4.56B 4.46B 193B 1.08B 930M 871M 796M 1.5B 103B 1.52B 10.27B 4B 52.18B 4.07B 3.98B 173B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
25/08/26 US$25.58 +1.47% 565,368
24/08/26 US$25.21 -3.26% 625,290
21/08/26 US$26.06 -0.46% 610,998
20/08/26 US$26.18 -1.21% 657,560
19/08/26 US$26.50 +3.35% 748,363
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
25.58USD
Average target price
40.83USD
Spread / Average Target
+59.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock